Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Drugs & Therapy Perspectives : for Rational Drug Selection and Use|April 1, 2020
Assessing the impact of structured education on the knowledge of hospital pharmacists about adverse drug reactions and reporting methods in Saudi Arabia: an open-label randomised controlled trialEjaz Cheema, Abdulmohsin Abdulaziz Almualem, Abdulmohsen Talal Basudan, et al.Drugs & Therapy Perspectives : for Rational Drug Selection and Use|July 23, 2019
Correction to: Afatinib in advanced NSCLC: a profile of its useEmma D Deeks, Gillian M KeatingDrugs & Therapy Perspectives : for Rational Drug Selection and Use|November 22, 2018
Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USAYoung-A HeoDrugs & Therapy Perspectives : for Rational Drug Selection and Use|January 26, 2019
Cabozantinib as first-line treatment in advanced renal cell carcinoma: a profile of its useKatherine A Lyseng-WilliamsonDrugs & Therapy Perspectives : for Rational Drug Selection and Use|March 22, 2022
Evaluation of three barrier-type closed system transfer devices using the 2015 NIOSH vapor containment performance draft protocolAndrew Szkiladz, Shawn HegnerDrugs & Therapy Perspectives : for Rational Drug Selection and Use|August 25, 2020
Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19Sikandar Hayat Khan, Sabeen Khurshid ZaidiDrugs & Therapy Perspectives : for Rational Drug Selection and Use|June 13, 2019
Correction to: Pirfenidone tablets in idiopathic pulmonary fibrosis: a profile of their useKatherine A Lyseng-WilliamsonDrugs & Therapy Perspectives : for Rational Drug Selection and Use|June 13, 2019
Correction to: Osimertinib as first-line therapy in advanced NSCLC: a profile of its useLesley J ScottDrugs & Therapy Perspectives : for Rational Drug Selection and Use|December 19, 2022
Nirmatrelvir plus ritonavir in COVID-19: a profile of its useHannah A BlairDrugs & Therapy Perspectives : for Rational Drug Selection and Use|August 9, 2021
Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systemsSunil Shrestha, Januka Khatri, Sujyoti Shakya, et al.Pageof 6